Figure 2
From: Prognosis value and positive association of Rab1A/IL4Rα aberrant expression in gastric cancer

IL-4Rα expression and Kaplan–Meier analysis of 115 GC patients. (A) IL-4Rα expression using IHC staining in 115 GC and para-cancer tissues (scale bar 100um). (B–D) The IHC score of IL-4Rα in (B) GC and para-cancer tissues, (C) GC with or without lymph node metastasis, (D) GC with TNM I–II or TNM III staging. (E–G) Kaplan–Meier analysis of IL-4Rα positive vs. IL-4Rα negative in (E) 115 GC patients, (F) GC patients with TMN I–II staging, and (G) GC patients with TMN III staging.